AR025455A1 - Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos - Google Patents

Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos

Info

Publication number
AR025455A1
AR025455A1 ARP000104536A ARP000104536A AR025455A1 AR 025455 A1 AR025455 A1 AR 025455A1 AR P000104536 A ARP000104536 A AR P000104536A AR P000104536 A ARP000104536 A AR P000104536A AR 025455 A1 AR025455 A1 AR 025455A1
Authority
AR
Argentina
Prior art keywords
contraception
mesoprogestines
conceptives
components
female
Prior art date
Application number
ARP000104536A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR025455A1 publication Critical patent/AR025455A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP000104536A 1999-08-31 2000-08-31 Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos AR025455A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
AR025455A1 true AR025455A1 (es) 2002-11-27

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104536A AR025455A1 (es) 1999-08-31 2000-08-31 Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos

Country Status (28)

Country Link
EP (1) EP1605949A2 (no)
JP (1) JP2003511399A (no)
KR (1) KR20020038745A (no)
CN (1) CN1384748A (no)
AR (1) AR025455A1 (no)
AU (1) AU781835B2 (no)
BG (1) BG106441A (no)
BR (1) BR0013711A (no)
CA (1) CA2383650A1 (no)
CO (1) CO5190694A1 (no)
CZ (1) CZ2002707A3 (no)
EA (1) EA006805B1 (no)
EE (1) EE200200103A (no)
HR (1) HRP20020265A2 (no)
HU (1) HUP0202515A3 (no)
IL (1) IL148415A0 (no)
LT (1) LT5001B (no)
LV (1) LV12940B (no)
MX (1) MXPA02002186A (no)
NO (1) NO20020998L (no)
NZ (1) NZ517470A (no)
PE (1) PE20010579A1 (no)
PL (1) PL353994A1 (no)
SI (1) SI20853A (no)
SK (1) SK2982002A3 (no)
UA (1) UA77150C2 (no)
WO (1) WO2001026603A2 (no)
YU (1) YU13902A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50304970D1 (de) * 2002-08-02 2006-10-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
EP1624848A4 (en) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
CA2571377C (en) * 2004-07-07 2014-03-25 Wyeth Cyclic progestin regimens and kits
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
PL2419108T3 (pl) 2009-04-14 2017-08-31 Laboratoire Hra Pharma Sposób antykoncepcji na żądanie
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4447715C2 (de) 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Behandlung von Prostatakarzinomen
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
AU707235B2 (en) * 1994-10-24 1999-07-08 Schering Aktiengesellschaft Competitive progesterone antagonists for demand-oriented female birth control
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
KR20000022189A (ko) * 1996-06-25 2000-04-25 에프.지.엠. 헤르만스;이.에이치. 리링크 프로제스토젠-항프로제스토젠 섭생
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CN1353717A (zh) * 1999-05-04 2002-06-12 莱加制药公司 四环黄体酮受体调节剂化合物及其方法

Also Published As

Publication number Publication date
CZ2002707A3 (cs) 2002-11-13
BR0013711A (pt) 2002-05-07
SI20853A (sl) 2002-10-31
WO2001026603A2 (en) 2001-04-19
BG106441A (bg) 2002-09-30
EA006805B1 (ru) 2006-04-28
CN1384748A (zh) 2002-12-11
YU13902A (sh) 2006-01-16
HUP0202515A3 (en) 2004-06-28
HUP0202515A2 (hu) 2002-12-28
EE200200103A (et) 2003-04-15
PE20010579A1 (es) 2001-06-04
LT2002035A (lt) 2002-10-25
UA77150C2 (en) 2006-11-15
NO20020998L (no) 2002-03-14
WO2001026603A3 (en) 2002-01-17
MXPA02002186A (es) 2002-09-02
PL353994A1 (en) 2003-12-15
CO5190694A1 (es) 2002-08-29
LV12940B (en) 2003-06-20
EA200200284A1 (ru) 2002-10-31
LT5001B (lt) 2003-03-25
AU781835B2 (en) 2005-06-16
NZ517470A (en) 2004-03-26
EP1605949A2 (en) 2005-12-21
CA2383650A1 (en) 2001-04-19
NO20020998D0 (no) 2002-02-28
HRP20020265A2 (en) 2004-02-29
IL148415A0 (en) 2002-09-12
AU3215001A (en) 2001-04-23
KR20020038745A (ko) 2002-05-23
SK2982002A3 (en) 2002-07-02
JP2003511399A (ja) 2003-03-25

Similar Documents

Publication Publication Date Title
CA2256365A1 (en) Compositions, methods and devices for the transdermal delivery of drugs
WO2006053172A3 (en) The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases
EP1260206A3 (en) Pants-type disposable wearing article
RU2005140277A (ru) Система доставки лекарственного вещества
DK0836506T3 (da) Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
DK1272504T3 (da) 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
AR048722A1 (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
ATE288744T1 (de) Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut
AR035904A1 (es) 5-[2-hidroxi-3-1-(3-trifluorometilfenil)-ciclopropil-propionilamino]-ftalida y compuestos relacionados con actividad moduladora del receptor de progesterona
AR025455A1 (es) Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos
EA200900451A1 (ru) Способ получения композиции эстрадиола с медленным высвобождением ( варианты ), микросферы эстрадиола и холестерина и способ для одновременной контрацепции и гормонозамещения
ES2162900T3 (es) Composicion liquida de l-n-mentol y procedimiento para su preparacion.
EA200100108A1 (ru) Применение биогенных сульфаматов эстрогенов для гормонзаместительной терапии
BR0214634A (pt) Sistemas terapêuticos transdérmicos contendo hormÈnio esteróide e contendo monocaprilato de propilenoglicol
PE20060318A1 (es) Forma de administracion para la contracepcion hormonal
ECSP055530A (es) Estratrienos 9-alfa-sustituidos como estrógenos de eficacia selectiva
BR0210272A (pt) Absorvente labial com dispositivo auxiliar para posicionamento e recepção de dedo
AR025457A1 (es) Mesoprogestinas (moduladores de receptores de progesterona) para el tratamiento y la prevencion de trastornos ginecologicos benignos hormona-dependientes
AR025456A1 (es) Mesoprogestinas (moduladores de receptor de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (trh)
BR0214334A (pt) Método para prover uma composição de base tópica para uso na preparação de uma composição cosmética, recipiente cosmético re-selável, e, composição anidra
Stockfleth Humane Papillomviren
AR033835A1 (es) Un producto para la higiene personal tal como una almohadilla para la higiene de la mujer
DE10250470A1 (de) Körperhygieneartikel aus saugfähigem Material - Urin-Rest-Absorber (URA) für Männer
CN2452478Y (zh) 髋部包扎带
BR0214333A (pt) Método para prover uma composição de base tópica para uso na preparação de uma composição cosmética, recipiente cosmético re-selável, e composição anidra

Legal Events

Date Code Title Description
FB Suspension of granting procedure